attempt rapidly appeared to be a response to perceived rejection. Throughout her hospitalization, Mrs O exhibited irritability, suggestibility, and poor insight.
Discussion
To our knowledge, this is the first report of MRI abnormalities in a patient with a factitious anemia. The first question raised is the link between the neurological symptoms and the MRI abnormalities. Although the diagnosis of multiple sclerosis cannot be invalidated, the absence of other objective neurological abnormalities does not support it. In this context, the subjective neurological complaints reported by the patient are consistent with the hypothesis of a neurological factitious disorder. The second remaining question is whether the MRI abnormalities that were found played a role in the development of factitious anemia.
This report raises an interesting question about cerebral lesions in the occurrence of pathomimia. To illuminate this association, we suggest further investigation to increase our understanding of the pathophysiology of factitious disorders. Jérémie Aouillé, MD Frédéric Rouillon, MD Frédéric Limosin, MD, PhD Créteil, France
Pregnancy and Respiratory Nocturnal Panic Attacks
Dear Editor:
Pregnancy may have a highly variable influence on the course of panic disorder (PD) (1) . Some case reports suggest that pregnancy protects against PD (2), but worsening or no change of PD during pregnancy is also reported (1).
We describe 2 women who were referred to the Laboratory of Panic and Respiration of the Federal University of Rio de Janeiro, with PD with prominent respiratory nocturnal panic attacks during pregnancy only.
Case Report 1
Mrs A, a 30-year-old white woman, started at age 26 years to have spontaneous diurnal attacks with palpitations, shortness of breath, choking, chest pain, dizziness, and fear of losing control. She was treated with imipramine (150 mg daily). After 18 months, she was asymptomatic and started to decrease the dosage. She had her first pregnancy after being free of psychotropic medications for 1 year. During the fourth month of pregnancy, however, she developed recurrent panic attacks during sleep. Her nocturnal panic attacks were intense and occurred almost nightly, with prominent respiratory symptoms (shortness of breath, chest pain, tingling, fear of dying and losing control, and severe choking). She never experienced nocturnal panic attacks before her pregnancy. She developed agoraphobic behaviour; she could only sleep seated, given her intense anticipatory anxiety at nightfall. She was initially treated with nortriptyline 10 mg daily. After 6 weeks, at the dosage of 75 mg daily, she achieved full remission of her respiratory nocturnal panic attacks. During her pregnancy, there was no diurnal panic attack. During the last 2 weeks of her pregnancy, nortriptyline was no longer prescribed. The asymptomatic period persisted after a 2-year follow-up.
Case Report 2
Mrs B, a 32-year-old white woman, began having diurnal panic attacks at age 22 years. During her panic attacks, the main symptoms were choking and shortness of breath. She was treated with paroxetine 20 mg daily. After 2 months, she no longer had panic attacks. For the next 32 months, she remained asymptomatic. During the fifth month of her second pregnancy, however, she started experiencing nocturnal panic attacks, with shortness of breath, chest pain, dyspnea, choking, paresthesias, sweating, tachycardia, and severe fear of dying. There was an intense anticipatory anxiety during sleep. She developed fear in falling asleep and performed her usual daily activities during the night. She was treated with nortriptyline and a dosage of 75 mg daily achieved complete remission. The drug was gradually discontinued during the last month of her pregnancy. At her 3-year follow-up, she had been without any panic attacks.
Discussion
The respiratory PD subtype appears as a distinct sample (3) . Nocturnal panic attacks are common, often neglected, and have been presenting with important respiratory symptoms. The physiology of the sleep, characterized by a significant rise of blood CO 2 (4), may explain why nighttime is favourable for developing panic attacks in patients with PD, a population characterized by heightened CO 2 sensitivity (4). Sex hormones influence respiration, and pregnancy is characterized by a strong physiologic fluctuation of their blood levels. The rise of progesterone levels may protect against panic attacks by facilitating GABA-ergic activity and by diminishing arterial CO 2 levels through increased minute ventilation (5); however, synthetic progesterones can cause severe dyspnea, tachypnea, and hyperventilation (6) , and estrogens can induce panic attacks (7) . We can conclude that, during pregnancy in some patients with PD, the balance among sex hormones may negatively effect respiratory sensitivity, thus inducing panic attacks. In addition, during nighttime, the pregnant woman's sleeping position may obstruct diaphragmatic breathing, modifying respiratory patterns to the extent that they enhance the possibility of nocturnal panic attacks.
